Evergreen Theragnostics was established in 2019 to be a leading US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO). Our team’s unmatched expertise and track record in theragnostic radiopharmaceutical commercialization, manufacturing process development, and regulatory affairs management, make us your idealpartner for all of your radiopharmaceutical development, manufacturing, and commercialization needs.

Biotechnology

Evergreen Theragnostics

James Cook

Nancy Preston

Patrick Nolty, MS

Zhen Hua Lin, R.T. (R)

Megha Thakkar, PhD

Dipesh Patel

Thomas Reiner

Phillip De Noble, PharmD

Michael Patrick

Kyle Hoffmann

Alton Kwong

Giacomo Pirovano

Alison Tillbrook

Alex Agnoletto

The Leadership Team at Evergreen Theragnostics is responsible for steering the company's strategic direction, overseeing key operational areas, and ensuring regulatory compliance. The team comprises top executives who lead scientific innovation, corporate governance, human resources, manufacturing and safety, quality and regulatory affairs, and financial management to drive the company's goals in radiopharmaceutical development and commercialization.

Leadership Team

Business Development and Strategy

Regulatory and Quality Assurance Team

Leadership Team

About

Team members

Other teams at Evergreen Theragnostics

Business Development and Strategy

Regulatory and Quality Assurance Team